After recognising tumour antigens presented by dendritic cells (DCs; which are professional APCs) in the secondary lymphoid organs, CD8+ T-cells become activated and differentiate into cytotoxic T lymphocytes (CTL), which may directly enact the killing of tumour cells in response to the recognition of tumour antigens [20]. The gene discussed is CD8A; the disease is neoplasm.